English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 3 August 2021, 18:00 HKT/SGT
Share:
    

Source: ClinTex (CTi)
ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App

LONDON, Aug 3, 2021 - (ACN Newswire) - The ClinTex (CTi) tokenized platform (clintex.io) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients.

ClinTex (CTi) launches 'Operational Excellence Module' (CTi-OEM) - a blockchain clinical trial application to tackle clinical trial inefficiencies and high costs. (ClinTex)

The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018, Clintex was formally working on the Clinical Trials Intelligence (CTi) platform. CTi's purpose is to deliver data analysis at scale, to drive collaboration and insights across clinical trials.

With large pharma companies like Merck and Novartis already testing blockchain as a technology of the future to support their clinical trial strategy for patient information and to manage clinical trial medication, this paves the way for ClinTex CTi to partner with the industry to deliver more innovative and impactful uses of blockchain to increase clinical trial efficiency.

The CTi-OEM App

Leveraging 50+ years of medicine development experience, ClinTex has moved at a breakneck pace to launch its first blockchain clinical trial app of the CTi Platform, the Operational Excellence Module (CTi-OEM). CTi-OEM provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff; allowing in-stream decision-making on what actions are required to ensure a successful investigation into the safety and efficacy of new medicines.

Using the CTi-OEM console, researchers can deep dive into clinical trial data and take proactive action to make clinical trials run more efficiently. These operational issues include things like clinical protocol deviations and adverse events relating to patient safety in the clinical trial.

The company has prioritized the development of the CTi-OEM blockchain clinical trial app to target some of the major causes of inefficiency in clinical trials, enabling its first app to derive maximum tangible benefits for the pharma and clinical trials industry. CTi-OEM achieves this through a comprehensive portfolio of tools, which is accessible through the CTi-OEM console.

Compliance Requirements & Patient Safety

One of the major obstacles to a successful clinical trial is adherence to the clinical trial protocol. Analytics within the CTi-OEM application allows the detection and analysis of these deviations and allows the clinical trial team to take speedy action. These tools provide powerful insights into the major causes of non-compliance in clinical trials providing analytics to help clinical trial teams identify and resolve them to speed up progress.

Protecting patient safety during a clinical trial is the most important aspect in the development of any new medicine. Adverse events are safety issues that occur during the testing of a new medicine. CTi-OEM provides valuable insight into patient safety throughout a clinical trial. For example, adverse event rate per site allows the clinical trial team to identify those sites that have a high rate of safety events which may point to procedural problems or may also uncover safety risks that need further investigation.

These are just a few examples of CTi-OEM's toolkit. For more information on CTi-OEM, there is a series of demonstration videos that give an overview of the platform, and how it can help alleviate pain points in clinical trials. Any clinical trial professionals interested in learning more or becoming early adopters can email ClinTex at industry@clintex.io or visit http://clinicaltrialsintelligence.org.

First Clinical Trials app on the CTi Platform

CTi-OEM is just the beginning for ClinTex offerings. Eventually, the platform will consist of 7 different blockchain clinical trial applications that derive intelligent analytics from all types of clinical trial data, and it is these analytics that can be used to drive efficiency in clinical trials. The ClinTex roadmap is on track to have live client onboarding and revenue generation by the end of 2022.

ClinTex Socials
Twitter : https://twitter.com/ClinTexCTi
Telegram : https://t.me/ClinTexCTi
Medium : https://medium.com/clintexcti
YouTube : https://youtu.be/iK3zkhsDzzA
Website : https://clintex.io/

Contact Details
Email: press@clintex.io

About ClinTex
ClinTex CTi (Clinical Trials Intelligence) is a solution provider to the pharmaceutical industry, a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials. Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

Topic: Press release summary
Source: ClinTex (CTi)

Sectors: Healthcare & Pharm, Blockchain Technology, Clinical Trials
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
BPipe Corporation, a Joint Venture Partner of Biopipe Global USA, enters into Agreement with Major Global Food Company to Install 10 m3/day Biopipe Biological Sewage Wastewater Treatment Plant  
Sept 27, 2022 20:00 HKT/SGT
SNS Network Technology Posts 42.4% Rise in Net Profit for 2Q FY2023  
Sept 27, 2022 19:00 HKT/SGT
MetaBoundless Hosts First-ever Avatar Concert in the Metaverse  
Sept 27, 2022 18:20 HKT/SGT
Metafluence Announces the Usage of Hyper-realistic Metahumans in the Metaverse  
Sept 27, 2022 16:00 HKT/SGT
DENSO Expands Vision Sensor Detection Angle for Subaru Legacy Outback, Crosstrek Models  
Tuesday, September 27, 2022 1:33:00 PM
Solar Energy Future MALAYSIA 2022 is on Fire  
Sept 27, 2022 09:00 HKT/SGT
Focally unveils the world's first Full colour Micro-led based true AR glasses with fully see-through display and USound MEMS speakers' technology  
Sept 27, 2022 09:00 HKT/SGT
Tech-titans unite to redefine the future of Cloud and Sustainable Data Centers in Dubai  
Sept 26, 2022 23:30 HKT/SGT
Less Than a Month to go for Jordan's Largest Tech Expo for Start-ups  
Sept 26, 2022 23:00 HKT/SGT
Hitachi Astemo Receives EV e-Axle Orders from Honda, and will Further Expand its Electrification Business  
Monday, September 26, 2022 7:25:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575